18 results
8-K
EX-1.1
5ecjuoi4
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
ewxf6i 6ht
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
8-K
EX-1.1
6mjd3 jp4tdq
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
liwb vg3xp1u
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
p228oe
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
op1fymaf57 jx
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
p627n7thfek
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
esuaokf852c
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-10.1
2l0rvu6a3 k0mqfz
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
424B3
e91 kcrnqop
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
prn4ksggwvfco go
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
qdh9cpi
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next